Director/PDMR shareholding - acquisition of shares

RNS Number : 3392T
Transense Technologies PLC
24 November 2021
 

24 November 2021

 

Transense Technologies plc

("Transense" or the "Company")

 

Director/PDMR shareholding - acquisition of shares

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, has been notified that on 23 November 2021 Ryan Maughan, who will join the board with effect from 1 December 2021, purchased 7,086 ordinary shares in the Company at £1.06p per share. Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 12,251 ordinary shares, which represents 0.075% of the issued share capital.

 

Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)  Via Walbrook PR

 

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)  Tel: +44 (0)20 3328 5656

 

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson  Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

 

 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring.  Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.  www.transense.com

For further information please contact  transense@walbrookpr.com .

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ryan Maughan

2

 

Reason for the notification

a)

 

Position/status

 

 

Director (designate)

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

 

 

Identification code

GB00BDHDTH21

 

 

b)

 

Nature of the transaction 

 

Purchase of Ordinary Shares

c)

Price and volume

Price: 106 pence per share

 

Volume: 7,086

d)

 

Aggregated information

 

- Aggregated volume

As above

- Price

 

 

 

e)

 

Date of the transaction

 

23 November 2021

f)

 

Place of the transaction

 

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGUGGUPGPUW
UK 100

Latest directors dealings